English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Book Chapter

Genetic imaging consortium for addiction medicine: From neuroimaging to genes

MPS-Authors
/persons/resource/persons138165

Sjoerds,  Zsuzsika
Department Neurology, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Mackey, S., Kan, K.-J., Chaarani, B., Alia-Klein, N., Batalla, A., Brooks, S., et al. (2016). Genetic imaging consortium for addiction medicine: From neuroimaging to genes. In H. Ekhtiari, & M. P. Paulus (Eds.), Neuroscience for addiction medicine: From prevention to rehabilitation; Methods and interventions (pp. 203-223). Amsterdam, the Netherlands: Elsevier. doi:10.1016/bs.pbr.2015.07.026.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002B-22EC-C
Abstract
Since the sample size of a typical neuroimaging study lacks sufficient statistical power to explore unknown genomic associations with brain phenotypes, several international genetic imaging consortia have been organized in recent years to pool data across sites. The challenges and achievements of these consortia are considered here with the goal of leveraging these resources to study addiction. The authors of this review have joined together to form an Addiction working group within the framework of the ENIGMA project, a meta-analytic approach to multisite genetic imaging data. Collectively, the Addiction working group possesses neuroimaging and genomic data obtained from over 10,000 subjects. The deadline for contributing data to the first round of analyses occurred at the beginning of May 2015. The studies performed on this data should significantly impact our understanding of the genetic and neurobiological basis of addiction.